Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
4.6 (681) · $ 19.99 · In stock
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
IJERPH, Free Full-Text
Psychiatry can match drugs to DNA for made-to-measure treatments - University of Mississippi Medical Center
A combined risk model shows viability for personalized breast
Benefits and Applications of Oncotype DX Breast Recurrence Score Testing among Breast Cancer Patients: Current Recommendations and Controversies.
Tumour-educated platelets for breast cancer detection: biological and technical insights
23andMe's New BRCA1/BRCA2 Report - 23andMe Blog
BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications - ScienceDirect
Mutational signatures for breast cancer diagnosis using artificial intelligence, Journal of the Egyptian National Cancer Institute
Frontiers Genomic Assays in Node Positive Breast Cancer Patients
Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK
The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients - ScienceDirect
Breast Cancer Prevention: Ways to Reduce Your Risk
Risk of Radiation-induced Breast Cancer from Mammographic Screening
3 Ways Genetic Counselors Support Your Health Care
